Cardio-oncology & otherCohort study
Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients
- Retrospective cohort study
- single-centre
- consecutive patients
Authors' conclusion
Our study identifies independent predictors of early and late cardiotoxicity, including demographic data, cardiovascular risk factors, history of cardiovascular disease, and oncologic history.
Study context
- Population
- Patients aged ≥15 years with haematologic malignancies undergoing allogeneic haematopoietic stem cell transplantation (alloHSCT), 2011–2020
- Participants
- 1,027 patients
- Outcome
- Cardiotoxicity (composite of CV death, HF, rhythm/conduction disorders, acute arterial events, VTE and myopericarditis)
Main finding
As reported in the abstract
Cardiotoxicity · median (IQR) follow-up 4 (1-7) years
Patients experiencing cardiotoxicity
30%
Median (IQR) time to first event
8 months (3-17)
Observational data: associations, not effects.
Original publication
Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients. Eur J Prev Cardiol. Published 30 September 2025. doi:10.1093/eurjpc/zwaf593
Summarised from the published abstract; every number is checked against it